Ohio State Navbar

News


Frontiers' Highlight - Steven Devine, MD


February 11, 2013

LESS IS MORE Reduced-Intensity Regimen Before BMT is Better for Older Leukemia Patients The rest of the story



Dec. 8: Ohio State’s 2012 Scarlet and Gray Reception at the


December 06, 2012

We look forward to meeting and collaborating with our colleagues during the 2012 ASH Annual Meeting and Exposition in Atlanta and seeing everyone at our reception on Saturday, Dec. 8, at the Omni Hotel at CNN Center, International Ballroom, 100 CNN Center, from 7:30-9:30 p.m. To RSVP, please click here. Questions? Contact Katie Jones at Katie.Jones@osumc.edu or (614) 366-5183. The rest of the story



Ohio State Lymphoma Specialist Elected to Prominent Scientific Advisory Board


December 06, 2012

Kristie Blum, MD, an associate professor and co-director of the Lymphoma Program in the Department of Internal Medicine’s Division of Hematology at Ohio State, has been elected to the Scientific Advisory Board for the Lymphoma Research Foundation. Read more: The rest of the story



Pelotonia 12 Brings 4-Year Total to More Tham $42 Million


December 06, 2012

Pelotonia, the fourth installment of an annual grassroots bicycle tour that raises millions of dollars for cancer research at the OSUCCC – James, has raised more than $42 million in the four years since it began in 2009. Riders and donors in Pelotonia 12 raised a record $16.8 million, a 28-percent increase over the Pelotonia 11 total of $13.1 million. Pelotonia 12, which took place Aug. 10-12 on routes between Columbus and Kenyon College in Gambier, Ohio, drew a record 6,212 riders, as well as 3,141 virtual riders and more than 2,000 volunteers. Thanks to the generosity of a few truly committed community sponsors who underwrite the costs of Pelotonia, 100% of every dollar raised by riders and donors goes directly to fund cancer research at Ohio State. The rest of the story



BLOOMFIELD RECEIVES NATIONAL SCHILSKY AWARD


July 10, 2012

Clara Bloomfield, MD, an international authority on leukemia and lymphoma at the OSUCCC – James, received the 2012 Richard L. Schilsky Cancer and Leukemia Group B (CALGB) Achievement Award from the Alliance for Clinical Trials in Oncology. The award acknowledges the significant contributions of an individual to cooperative group research. Dr. Bloomfield conducted seminal work showing that the type of chromosome changes often predicted a patient’s response to therapy. Read more about her award here. The rest of the story



CHRONIC LEUKEMIA MARKER DISTINGUISHES MORE- VS. LESS-AGGRESSIVE FORMS


July 02, 2012

Researchers at the OSUCCC – James have identified a prognostic marker in the most common form of chronic leukemia that can help to distinguish which patients should start treatment quickly from those who can safely delay treatment, perhaps for years The rest of the story



EXPERIMENTAL AGENT MAY HELP OLDER PEOPLE WITH CHRONIC LEUKEMIA


June 04, 2012

The experimental drug ibrutinib (PCI-32765) shows great promise for treating elderly patients with chronic lymphocytic leukemia (CLL) The rest of the story



Steven Devine, MD, appointed as Clinical Trials Office (CTO) Medical Director for Hematologic Malignancies


May 31, 2012

Steven Devine, MD, appointed as Clinical Trials Office (CTO) Medical Director for Hematologic Malignancies The rest of the story



Please join us June 2 for Ohio State's Scarlet & Gray Reception at ASCO's Annual Meeting


May 16, 2012

Please join us June 2 for Ohio State's Scarlet & Gray Reception at ASCO's Annual Meeting The rest of the story



Myeloma Drug Showing Promise


May 10, 2012

The Columbus Dispatch is taking notice of a promising new treatment in Multiple Myeloma. Dr Craig Hofmeister and Dr. Steven Devine sat down with The Columbus Dispatch to discuss this exciting treatment, which will also be featured in the New England Journal of Medicine. The rest of the story



Previous     Next